Velpatasvir And Sofosbuvir + Rosuvastatin Interaction
Moderateinteraction on record
Description
HMG-CoA Reductase Inhibitors: rosuvastatin ↑ rosuvastatin Coadministration of EPCLUSA with rosuvastatin may significantly increase the concentration of rosuvastatin, which is associated with increased risk of myopathy, including rhabdomyolysis. Rosuvastatin may be administered with EPCLUSA at a dose that does not exceed 10 mg.
Source: FDA drug label - velpatasvir and sofosbuvir